Antonio Carlos Pedroso de Lima
Overview
Explore the profile of Antonio Carlos Pedroso de Lima including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
125
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gurgel A, Augusto Coelho Guimaraes J, Brum P, Carlos Pedroso de Lima A, Giavina-Bianchi P, Henrique Mesquita Peres C, et al.
Prev Med Rep
. 2024 Jan;
38:102587.
PMID: 38288262
Introduction: The COVID-19 pandemic may lead to reduced physical activity (PA) in health care workers (HCWs). Objective: To evaluate leisure and transport-related PA in HCW of a COVID-19-dedicated hospital during...
2.
Brandao S, Brunner-La Rocca H, Carlos Pedroso de Lima A, Bocchi E
Medicine (Baltimore)
. 2023 Oct;
102(42):e35614.
PMID: 37861539
Cost-effectiveness analysis has long been practiced; registries date back to the United States of America War Department in 1886. In addition, everyone does intuitive cost-effectiveness analyses in their daily lives....
3.
Freire M, Assis D, de Melo Tavares B, Brito V, Marinho I, Lapchik M, et al.
Clinics (Sao Paulo)
. 2023 Jun;
78:100231.
PMID: 37348255
Background: This study aimed to analyze the Healthcare-Associated Infections (HAI) rates and antimicrobial consumption in Intensive Care Units (ICU) in São Paulo city during the COVID-19 pandemic and compare them...
4.
Lederman C, Ferreira J, Albuquerque C, Carlos Pedroso de Lima A, Barroso L, Souza J, et al.
Medicine (Baltimore)
. 2023 Apr;
102(16):e33627.
PMID: 37083767
It is critically important for stakeholders with distinct foci of attention on healthcare to understand patient evolution in the presence of an established diagnosis or with a suspected diagnosis of...
5.
Razzolini M, Barbosa M, de Araujo R, Freitas de Oliveira I, Mendes-Correa M, Sabino E, et al.
Environ Pollut
. 2021 Aug;
290:118003.
PMID: 34425371
COVID-19 pandemic has led to concerns on the circulation of SARS-CoV-2 in the environment, its infectivity from the environment and, the relevance of transmission via environmental compartments. During 31 weeks,...
6.
Assis G, Benuti G, Moretto M, Vidigal C, Santos R, Lobo R, et al.
Am J Infect Control
. 2021 Jan;
49(7):879-884.
PMID: 33465447
Background: Most bloodstream infections related to vascular catheters can be avoided if evidence-based practices are applied during insertion and maintenance. In practice, adherence by health care workers (HCWs) is unsatisfactory...
7.
Geremias Dos Santos H, Zampieri F, Normilio-Silva K, Silva G, Carlos Pedroso de Lima A, Biasi Cavalcanti A, et al.
J Crit Care
. 2019 Nov;
55:73-78.
PMID: 31715534
Purpose: To develop and compare the predictive performance of machine-learning algorithms to estimate the risk of quality-adjusted life year (QALY) lower than or equal to 30 days (30-day QALY). Material...
8.
Dombrowski J, de Souza R, Lima F, Bandeira C, Murillo O, de Sousa Costa D, et al.
JAMA Netw Open
. 2019 May;
2(5):e193300.
PMID: 31050780
Importance: Malaria during pregnancy is associated with adverse events for the fetus and newborn, but the association of malaria during pregnancy with the head circumference of the newborn is unclear....
9.
Brandao S, Rezende P, Brunner-La Rocca H, Ju Y, Carlos Pedroso de Lima A, Takiuti M, et al.
Cost Eff Resour Alloc
. 2018 Nov;
16:55.
PMID: 30410425
Background: The costs for treating coronary artery disease (CAD) are high worldwide. We performed a prespecified analyses of cost-effectiveness of three therapeutic strategies for multivessel CAD. Methods: From May 1995...
10.
Brandao S, Hueb W, Ju Y, Carlos Pedroso de Lima A, Polanczyk C, Cruz L, et al.
Medicine (Baltimore)
. 2018 Feb;
96(50):e9113.
PMID: 29390308
Objectives: This study evaluated the utility and quality-of-life year measurements for patients with coronary artery disease who underwent any of 3 therapeutic strategies with a 5-year follow-up. Methods: Quality-of-life data...